Body Composition as a Predictor of Toxicity and Prognosis in Patients with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy

Guo, JX; Cai, PP; Li, PF; Cao, C; Zhou, J; Dong, LN; Yang, Y; Xuan, QJ; Wang, JX; Zhang, QY

Wang, JX; Zhang, QY (corresponding author), Harbin Med Univ Canc Hosp, Dept Med Oncol, Harbin 150040, Peoples R China.

CURRENT ONCOLOGY, 2021; 28 (2): 1325

Abstract

Background: Our study measured the body composition of Diffuse large B-cell lymphoma (DLBCL) patients receiving rituximab with cyclophosphamide, doxor......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索